BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Genetown

  PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development

  PAREXEL today launched its Biological Sample Lifecycle Management service, enabling optimal use of human biological samples.

  February 12, 2018

   · 

  3 min read
• Drug Development

  Dermira Showcases Commitment to Hyperhidrosis Education and Treatment at Leading Dermatology Conference

  The event is taking place in San Diego, February 16-20.

  February 12, 2018

   · 

  7 min read
• Policy

  BioCorRx Announces Results of Pre-IND meeting with FDA for Sustained Release Naltrexone Implant, BICX102

  In addition, the Company announced that based on the FDA’s responses, it plans to apply for dual indications, both opioid use disorder and alcohol use disorder, within the same application.

  February 12, 2018

   · 

  3 min read
• Business

  TraceLink Achieves 97% Revenue Growth in Q4 and 85% Overall Revenue Growth for 2017

  An 85 percent year-over-year increase in overall revenue for 2017.

  February 12, 2018

   · 

  4 min read
• BioCapital

  CEL-SCI to Present Tomorrow at 2018 BIO CEO & Investor Conference

  CEL-SCI announced that Geert Kersten, Chief Executive Officer, will be presenting at the 2018 BIO CEO & Investor Conference on Tuesday, February 13, 2018 at 9:45 a.m.

  February 12, 2018

   · 

  1 min read
• Biotech Beach

  Capricor to Give Update on HOPE-2 Clinical Trial for CAP-1002 at International Conference on Duchenne Muscular Dystrophy

  The three-day conference brings together scientists, physicians, companies, patients and their families to discuss the latest developments in Duchenne and Becker muscular dystrophy.

  February 12, 2018

   · 

  4 min read
• PositiveID’s Chief Science Officer Co-Authors Report on Need for Department of Homeland Security’s National Biosurveillance Integration Center

  NBIC was established to help thwart the real threat of bioterrorism attacks in the U.S.

  February 12, 2018

   · 

  4 min read
• Business

  Spring Bank to Host Conference Call to Discuss Fourth Quarter and Fiscal Year 2017 Results on Wednesday, February 21

  The company will provide its 2018 development outlook at 8:30am Eastern Time on Wednesday, February 21, 2018.

  February 12, 2018

   · 

  1 min read
• Drug Development

  Rexahn Reports Data From the Ongoing Phase IIa Clinical Trial of RX-3117 in Advanced Bladder Cancer at the American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) 2018 Annual Meeting

  The poster presentation reported interim data on the Phase 2a clinical trial of RX-3117 monotherapy for the treatment of advanced bladder cancer.

  February 12, 2018

   · 

  6 min read
• Business

  Evogene Financial Results for the Fourth Quarter and Full Year 2017 Earnings Announcement Schedule

  The Company’s management will host a conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time. T

  February 12, 2018

   · 

  2 min read